Friday 6 November 2026 Export ZTS’s income statement to Excel — free account

Zoetis Inc.

ZTS Healthcare Drug Manufacturers Specialty & Generic

Zoetis Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, up 2.28% from fiscal 2024.

Revenue: −0.24%
EPS: +2.48%
Free cash flow: +17.4%
Total debt: +37.5%

Quarter to June 2026, against a year earlier

79.36 2.75 −3.35%

Follow ZTS

Alert me

Market cap: $33.9B
P/E: 13.4×
Fwd P/E: 14.2×
Dividend yield: 2.59%
F-score: 7/9
Altman Z: 5.73
Beneish M: −2.45
Dividend safety: 88/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	11.82	19.57	21.11	24.93	+8 more quarters Free account
P/S ratio Full definition →	3.15	5.24	5.89	6.90
P/FCF ratio Full definition →	12.90	22.21	24.44	28.93
P/Operating CF Full definition →	45.81	124.43	62.48	72.73
P/B ratio Full definition →	9.53	15.43	16.34	12.01
Price to Tangible BV Full definition →	0.00	0.00	0.00	40.66
EV/Sales Full definition →	4.07	6.12	6.73	7.58
EV/EBITDA Full definition →	9.64	14.37	15.66	17.75
EV/Operating CF Full definition →	13.64	20.91	21.95	24.40
EV/FCF Full definition →	16.64	25.97	27.92	31.76
Quick Ratio Full definition →	1.58	1.68	1.78	2.01
Current Ratio Full definition →	3.08	3.15	3.12	3.64
Net Debt/EBITDA Full definition →	7.05	7.57	6.82	4.67
Debt/Assets Full definition →	60.01%	59.69%	58.37%	46.63%
Debt/Equity Full definition →	2.87	2.80	2.65	1.31
Asset Turnover Full definition →	0.64	0.65	0.64	0.64
Operating CF/Net income Full definition →	0.95	0.67	1.43	1.24
Capex/Depreciation Full definition →	(0.97)	(0.84)	(1.34)	(1.10)
Interest Coverage Full definition →	15.20	13.23	14.82	16.29
Research and Development Expense of Revenue Full definition →	7.01%	7.96%	8.35%	7.08%
Selling, General and Administrative Expense of Revenue Full definition →	23.99%	25.99%	25.51%	24.13%
Intangible Assets out of Total Assets Full definition →	0.24	0.25	0.24	0.25
Share Based Compensation of Revenue Full definition →	1.05%	1.11%	0.92%	0.92%
Graham Net Nets Full definition →	(0.19)	(0.11)	(0.09)	(0.05)
Graham Number Full definition →	32.11	32.26	32.14	40.12
Earnings Yield Full definition →	8.46%	5.11%	4.74%	4.01%
Free Cash Flow Yield Full definition →	7.75%	4.50%	4.09%	3.46%
Revenue per Share Full definition →	5.91	5.36	5.40	5.42
Operating CF per Share Full definition →	1.57	0.95	2.01	2.01
Capex per Share Full definition →	(0.28)	(0.24)	(0.37)	(0.30)
Free Cash Flow per Share Full definition →	1.29	0.71	1.65	1.71
Cash per Share Full definition →	4.01	4.60	5.52	4.71
Shareholders Equity per Share Full definition →	7.54	7.66	7.70	12.19
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	7.54	7.66	7.70	12.19
Free Cash Flow Full definition →	539.00	301.00	731.00	756.00
Working Capital Full definition →	4,295.00	4,421.00	4,600.00	4,776.00
Capital Expenditures Full definition →	(116.00)	(100.00)	(162.00)	(135.00)
Net Current Asset Value Full definition →	(5,573.00)	(5,447.00)	(5,302.00)	(3,178.00)
EV/EBIT Full definition →	10.95	16.32	17.79	20.21
Capex to Sales Full definition →	0.05	0.04	0.07	0.06
Price to Operating Income Full definition →	9.10	14.92	16.61	19.61
Other line items
Average Receivables Full definition →	1,555.50	1,433.50	1,362.50	1,476.00
Average Payables Full definition →	480.00	463.50	439.00	407.00
Average Inventory Full definition →	2,506.50	2,457.50	2,385.00	2,440.50
Average Assets Full definition →	14,778.00	14,626.00	14,863.50	14,758.00
Average Common Equity Full definition →	4,062.50	3,944.00	4,092.50	5,316.00

Show all line items

Columns are period end dates · fundamentals updated 25 Oct 2026

Stockrow Weekly